NMRD News and Press, Nemaura Medical Inc.

NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take pla...

Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions that will imp...

2023-12-13 09:44:35 ET More on Nemaura Medical Nemaura Medical says compliance regain with Nasdaq rules not expected Seeking Alpha’s Quant Rating on Nemaura Medical Historical earnings data for Nemaura Medical Financial information for Nemaura Medical ...

Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel gr...

2023-11-21 09:33:08 ET More on Nemaura Medical Nemaura Medical says compliance regain with Nasdaq rules not expected Seeking Alpha’s Quant Rating on Nemaura Medical Historical earnings data for Nemaura Medical Financial information for Nemaura Medical ...

Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce the execution of a strategic agre...

Nemaura Medical Inc. (NMRD) is expected to report $-0.1 for Q2 2024

Nemaura Medical (NASDAQ: NMRD) , a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, is reporting on its financial and business results for the quarter ended Sept. 30, 2023, a...

Company CEO to discuss development at 1pm EST on 15 th November 2023, at the Sidoti Virtual Investor Conference Loughborough, UK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, developer of a daily wear non-invasive glucose sensor, and digital healthcare programs today announc...

2023-11-13 17:33:21 ET More on Nemaura Medical Nemaura Medical says compliance regain with Nasdaq rules not expected Seeking Alpha’s Quant Rating on Nemaura Medical For further details see: Nemaura Medical reports Q2 results